ALK and anaplastic large cell lymphoma: Unfortunately, due to the lack of widely accepted diagnostic criteria or reliable biomarkers to differentiate between ALK- ALCL and CD30high PTCL, NOS, accurately diagnosing these two conditions remains a challenge and requires careful consideration of clinical, morphological, and immunophenotypic features by an experienced pathologist.